Zelgen Biopharmaceuticals’ Jacktinib Wins FDA Approval for Severe Alopecia Areata
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) secured U.S. FDA approval to launch a clinical...
Jacobio Pharmaceuticals Doses First Patient in JAB-BX102 Phase I/IIa Trial for CD73-Targeted Cancer Therapy
China’s Jacobio Pharmaceuticals Group Co., Ltd (HKG: 1167) announced the first patient dosed in a...
Northeast Pharma Licenses MedAbome’s MAb11-22.1 for ADC and CAR-T Development
China’s Northeast Pharmaceutical Co., Ltd (SHE: 000597) has signed a licensing agreement with U.S.-based MedAbome...
Alphamab Oncology Highlights KN046, KN026 Advances at ESMO 2022
China’s Alphamab Oncology (HKG: 9966) will present updated clinical data for its bispecific antibody candidates...
AstraZeneca’s Farxiga Wins China Approval for Chronic Kidney Disease
UK pharma giant AstraZeneca (AZ, NASDAQ: AZN) announced a new approval for Farxiga (dapagliflozin), its...
Innovent Biologics Doses First Patient in Higher-Dose Mazdutide Obesity Trial
China’s Innovent Biologics, Inc. (HKG: 1801) announced that the first participant has been dosed in...
Shanghai Pharma’s CD20 Antibody Advances to Primary Nephropathy Trial After NMPA Approval
China’s Shanghai Pharmaceuticals (HKG: 2607, SHA: 601607) has received approval from the National Medical Products...
Walvax Biotech Wins NMPA Approval for mRNA and Recombinant COVID-19 Vaccines
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) has received clinical trial approvals from the National...
Medim Science Raises Funds for Macrophage-Targeting Biologics in Cancer Therapy
Hangzhou-based Medim Science, China’s first pharma firm focused on macrophage-targeting biologics, has reportedly raised tens...
China’s Pharmaceutical Industry Sees Revenue Decline Amid Export Shifts
China’s pharmaceutical manufacturing sector reported a 1.8% year-on-year (YOY) revenue decline to RMB 1.6 trillion...
Tibet Duo Rui and Nanjing Heron Forge Pharmaceutical Collaboration in China
China-based Tibet Duo Rui Pharmaceutical Co., Ltd and Nanjing Heron Pharmaceutical Science and Technology Co.,...
CARsgen Therapeutics Launches GMP Manufacturing for CAR-T Cell Therapies in North Carolina
China’s CARsgen Therapeutics Holdings Ltd (HKG: 2171), a chimeric antigen receptor (CAR)-T cell specialist, has...
MegaRobo and Danaher Life Sciences Partner on Lab Automation in China
Beijing-based MegaRobo Technologies, a robotics and AI firm in life sciences, has partnered with Danaher...
Hengrui Medicine’s HRG2101 Inhaler Wins NMPA Approval for IPF Clinical Trial
China’s Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276) has received approval from the National Medical...
U Protech Secures Angel Financing for PROTAC and Molecular Glue Drug Pipeline
U Protech, a Hangzhou-based biotech focused on next-generation protein degradation therapies, has raised tens of...
J&J China, Tencent Launch Digital Rhinitis Platform “Love Nose e-Station”
Johnson & Johnson’s (J&J, NYSE: JNJ) J&J China Self Care and China’s Tencent have launched...
Neukio Biotherapeutics Completes USD 50M Series A-1 Financing for iPSC-CAR-NK Therapy
Shanghai-based Neukio Biotherapeutics, a developer of iPSC-derived chimeric antigen receptor natural killer (CAR-NK) cell therapies,...
Acorda Therapeutics Licenses Preclinical Drug Nepicastat to China’s Asieris
US-based Acorda Therapeutics Inc. (Nasdaq: ACOR) announced a licensing agreement with China’s Asieris Pharmaceuticals for...
SAMR Issues New Rules for Online Drug Sales in China
China’s State Administration for Market Regulation (SAMR) has released the “Measures for the Supervision and...
NMPA Designates Shijiazhuang Airport as Drug Import Port for Narcotics, Psychotropics
China’s National Medical Products Administration (NMPA) has designated Shijiazhuang Airport in Hebei Province as an...